Chapter/Section Purchase

1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Global Risperidone Outlook 2017 VS 2022 VS 2028
1.2.1 Global Risperidone Sales in US$ Million for the Year 2017-2028
1.2.2 Global Risperidone Sales in Volume for the Year 2017-2028
1.3 United States Risperidone Outlook 2017 VS 2022 VS 2028
1.3.1 United States Risperidone Sales in US$ Million for the Year 2017-2028
1.3.2 United States Risperidone Sales in Volume for the Year 2017-2028
1.4 Risperidone Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Risperidone in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Risperidone Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Risperidone Market Dynamics
1.5.1 Risperidone Industry Trends
1.5.2 Risperidone Market Drivers
1.5.3 Risperidone Market Challenges
1.5.4 Risperidone Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Risperidone Market Segment by Type
2.1.1 Oral
2.1.2 Injectable
2.2 Global Risperidone Market Size by Type
2.2.1 Global Risperidone Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Risperidone Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Risperidone Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Risperidone Market Size by Type
2.3.1 United States Risperidone Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Risperidone Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Risperidone Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Risperidone Market Segment by Application
3.1.1 Schizophrenia
3.1.2 Bipolar Disorder
3.2 Global Risperidone Market Size by Application
3.2.1 Global Risperidone Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Risperidone Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Risperidone Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Risperidone Market Size by Application
3.3.1 United States Risperidone Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Risperidone Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Risperidone Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Risperidone Competitor Landscape by Company
4.1 Global Risperidone Market Size by Company
4.1.1 Top Global Risperidone Manufacturers Ranked by Revenue (2021)
4.1.2 Global Risperidone Revenue by Manufacturer (2017-2022)
4.1.3 Global Risperidone Sales by Manufacturer (2017-2022)
4.1.4 Global Risperidone Price by Manufacturer (2017-2022)
4.2 Global Risperidone Concentration Ratio (CR)
4.2.1 Risperidone Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Risperidone in 2021
4.2.3 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Risperidone Manufacturing Base Distribution, Product Type
4.3.1 Global Risperidone Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Risperidone Product Type
4.3.3 Date of International Manufacturers Enter into Risperidone Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Risperidone Market Size by Company
4.5.1 Top Risperidone Players in United States, Ranked by Revenue (2021)
4.5.2 United States Risperidone Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Risperidone Sales by Players (2020, 2021 & 2022)
5 Global Risperidone Market Size by Region
5.1 Global Risperidone Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Risperidone Market Size in Volume by Region (2017-2028)
5.2.1 Global Risperidone Sales in Volume by Region: 2017-2022
5.2.2 Global Risperidone Sales in Volume Forecast by Region (2023-2028)
5.3 Global Risperidone Market Size in Value by Region (2017-2028)
5.3.1 Global Risperidone Sales in Value by Region: 2017-2022
5.3.2 Global Risperidone Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Risperidone Market Size YoY Growth 2017-2028
6.1.2 North America Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Risperidone Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Risperidone Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Risperidone Market Size YoY Growth 2017-2028
6.3.2 Europe Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Risperidone Market Size YoY Growth 2017-2028
6.4.2 Latin America Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Risperidone Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Risperidone Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Janssen Pharmaceutica
7.1.1 Janssen Pharmaceutica Corporation Information
7.1.2 Janssen Pharmaceutica Description and Business Overview
7.1.3 Janssen Pharmaceutica Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Janssen Pharmaceutica Risperidone Products Offered
7.1.5 Janssen Pharmaceutica Recent Development
7.2 Teva
7.2.1 Teva Corporation Information
7.2.2 Teva Description and Business Overview
7.2.3 Teva Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Teva Risperidone Products Offered
7.2.5 Teva Recent Development
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Corporation Information
7.3.2 Sun Pharmaceutical Description and Business Overview
7.3.3 Sun Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Sun Pharmaceutical Risperidone Products Offered
7.3.5 Sun Pharmaceutical Recent Development
7.4 Aurobindo
7.4.1 Aurobindo Corporation Information
7.4.2 Aurobindo Description and Business Overview
7.4.3 Aurobindo Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Aurobindo Risperidone Products Offered
7.4.5 Aurobindo Recent Development
7.5 Cipla
7.5.1 Cipla Corporation Information
7.5.2 Cipla Description and Business Overview
7.5.3 Cipla Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Cipla Risperidone Products Offered
7.5.5 Cipla Recent Development
7.6 Invent Farma Group
7.6.1 Invent Farma Group Corporation Information
7.6.2 Invent Farma Group Description and Business Overview
7.6.3 Invent Farma Group Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Invent Farma Group Risperidone Products Offered
7.6.5 Invent Farma Group Recent Development
7.7 Medichem
7.7.1 Medichem Corporation Information
7.7.2 Medichem Description and Business Overview
7.7.3 Medichem Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Medichem Risperidone Products Offered
7.7.5 Medichem Recent Development
7.8 Interquim
7.8.1 Interquim Corporation Information
7.8.2 Interquim Description and Business Overview
7.8.3 Interquim Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Interquim Risperidone Products Offered
7.8.5 Interquim Recent Development
7.9 IPCA
7.9.1 IPCA Corporation Information
7.9.2 IPCA Description and Business Overview
7.9.3 IPCA Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.9.4 IPCA Risperidone Products Offered
7.9.5 IPCA Recent Development
7.10 RPG
7.10.1 RPG Corporation Information
7.10.2 RPG Description and Business Overview
7.10.3 RPG Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.10.4 RPG Risperidone Products Offered
7.10.5 RPG Recent Development
7.11 Sharon
7.11.1 Sharon Corporation Information
7.11.2 Sharon Description and Business Overview
7.11.3 Sharon Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sharon Risperidone Products Offered
7.11.5 Sharon Recent Development
7.12 Torrent Pharmaceuticals
7.12.1 Torrent Pharmaceuticals Corporation Information
7.12.2 Torrent Pharmaceuticals Description and Business Overview
7.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Torrent Pharmaceuticals Products Offered
7.12.5 Torrent Pharmaceuticals Recent Development
7.13 Temad
7.13.1 Temad Corporation Information
7.13.2 Temad Description and Business Overview
7.13.3 Temad Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Temad Products Offered
7.13.5 Temad Recent Development
7.14 Wuxi Jida
7.14.1 Wuxi Jida Corporation Information
7.14.2 Wuxi Jida Description and Business Overview
7.14.3 Wuxi Jida Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Wuxi Jida Products Offered
7.14.5 Wuxi Jida Recent Development
7.15 Changzhou Siyao Pharmaceuticals
7.15.1 Changzhou Siyao Pharmaceuticals Corporation Information
7.15.2 Changzhou Siyao Pharmaceuticals Description and Business Overview
7.15.3 Changzhou Siyao Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Changzhou Siyao Pharmaceuticals Products Offered
7.15.5 Changzhou Siyao Pharmaceuticals Recent Development
7.16 Ningbo Team Pharm
7.16.1 Ningbo Team Pharm Corporation Information
7.16.2 Ningbo Team Pharm Description and Business Overview
7.16.3 Ningbo Team Pharm Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Ningbo Team Pharm Products Offered
7.16.5 Ningbo Team Pharm Recent Development
7.17 Zhejiang Huahai Pharmaceutical
7.17.1 Zhejiang Huahai Pharmaceutical Corporation Information
7.17.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
7.17.3 Zhejiang Huahai Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Zhejiang Huahai Pharmaceutical Products Offered
7.17.5 Zhejiang Huahai Pharmaceutical Recent Development
7.18 TIPR
7.18.1 TIPR Corporation Information
7.18.2 TIPR Description and Business Overview
7.18.3 TIPR Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.18.4 TIPR Products Offered
7.18.5 TIPR Recent Development
7.19 Qilu Pharmaceutical
7.19.1 Qilu Pharmaceutical Corporation Information
7.19.2 Qilu Pharmaceutical Description and Business Overview
7.19.3 Qilu Pharmaceutical Risperidone Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Qilu Pharmaceutical Products Offered
7.19.5 Qilu Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Risperidone Industry Chain Analysis
8.2 Risperidone Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Risperidone Distributors
8.3 Risperidone Production Mode & Process
8.4 Risperidone Sales and Marketing
8.4.1 Risperidone Sales Channels
8.4.2 Risperidone Distributors
8.5 Risperidone Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer